Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
AAN, abide, abroad, ACA, add, adequacy, age, aging, anesthesiologist, attack, behavioral, Berkshire, bilateral, biomarker, biopharmaceutical, birtamimab, Brexit, Bristol, broadly, cardiac, Catalent, categorized, CCPA, certified, chain, chronic, circulating, clarify, clonal, cognizant, commerce, complement, complicated, compulsory, conception, concert, concurrent, confirmatory, conflicting, confusion, constantly, constitutionality, content, cooperation, core, correctly, counsel, CPRA, creation, CTE, cybersecurity, degenerative, delete, Department, deplete, depleter, Depository, diagnosed, differentiated, diminish, disagreement, displaying, distance, division, documentary, domestic, downstream, draft, DTA, efficient, efficiently, electrical, emerge, encephalopathy, entail, equitable, eroding, Europe, evidenced, expend, expenditure, exploit, extracellular, Fast, faster, fastest, fatal, feasible, featuring, fibril, formation, forward, fourth, frequently, geographic, GLS, goodwill, grace, growing, heart, heavily, hereditary, highest, highlighted, highlighting, history, identification, immunoglobulin, inadvertent, incorrectly, inhibit, injunction, injunctive, insoluble, internet, intervene, intraneuronal, inventorship, Justice, kappa, lambda, landscape, lapse, latitude, lawsuit, learned, lifespan, lifetime, light, line, lodge, longer, longitudinal, maintenance, mature, Mayo, mechanism, media, medium, mice, microtubule, misappropriated, misappropriation, mission, misuse, monotherapy, month, mortality, MTBR, multicenter, narrow, narrowed, native, neuropathy, neurotoxicity, NIS, noncompliance, notification, nurse, official, oppose, Orphan, overrule, overwhelming, pace, PADOVA, PADVOA, palsy, partnership, PCS, people, persistence, perspective, Pharma, phishing, plasma, platform, police, poor, postpone, postponed, prejudiced, presumption, principle, prioritization, prioritize, procedural, prompted, PSP, question, rapidly, ratified, redesign, region, regional, regular, Relatedly, repeal, reproduce, Rescue, reservation, resolved, restoration, resume, resumption, revoke, robust, sabotage, seeding, senior, sensitive, shortly, sophisticated, sophistication, SPA, Sterile, strong, subgroup, subpoena, superior, supervisory, supranuclear, Supreme, survival, survive, susceptible, symptomatic, symptomatology, systolic, telecommunication, temporarily, terrorism, tetramer, tetrameric, thereon, threat, today, transgenic, traumatic, treble, Trust, TTR, UK, unclear, underwriting, undetected, Unified, unintentional, unrecognized, untreated, uptake, urgent, vi, vital, vitro, vivo, war, weaken, weakened, whilst, wild, win, writing, York
Removed:
absolute, adjustment, alpha, bear, calendar, cautioned, ceased, conform, dementia, discontinuing, employer, encountered, estimating, expanding, FASB, franchise, frontotemporal, GmbH, guilty, Historically, HITECH, initiative, invalidate, liquidation, mind, possession, PSG, purpose, reclassified, removal, reorganization, retrospective, safeguarding, simplification, superseded, switch, undue, week, workforce
Filing tables
Filing exhibits
Related press release
PRTA similar filings
Filing view
External links
Exhibit 10.2
SEVENTH AMENDMENT TO THE
PROTHENA CORPORATION PLC
2020 EMPLOYMENT INDUCEMENT INCENTIVE PLAN
This Seventh Amendment (this “Seventh Amendment”) to the Prothena Corporation plc 2020 Employment Inducement Incentive Plan (“2020 EIIP”), was made and adopted by the Board of Directors (“Board”) of Prothena Corporation plc, a public limited company organized under the laws of Ireland (the “Company”), on February 1, 2021 (the “Amendment Date”).
RECITALS
WHEREAS, the Company maintains the 2020 EIIP; and
WHEREAS, the Board believes it is in the best interests of the Company and its shareholders to amend the 2020 EIIP to increase the number of ordinary shares authorized for issuance under the 2020 EIIP.
NOW, THEREFORE, BE IT RESOLVED, that the 2020 EIIP is hereby amended as follows, effective as of the Amendment Date:
AMENDMENT
1.Section 2.28 of the 2020 EIIP is hereby amended and restated in its entirety as follows:
“2.28 “Overall Share Limit” means 785,000 Shares.”
2.This Seventh Amendment shall be and hereby is incorporated into and forms a part of the 2020 EIIP, and except as expressly provided herein, all terms and conditions of the 2020 EIIP shall remain in full force and effect.